Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06785636
Title Open-Label Study of Pocenbrodib and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 (P300)
Acronym P300
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Pathos AI, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.